Search Clinical Trials
583,298 trials
ID
Status
Phase
Title
Sponsor
NCT07569692
(PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulnerable Plaque Evaluated by CoroNary Computed Tomography Angiography)-2CardioVascular Research Foundation, KoreaNot Yet RecruitingNot Applicable
NCT07569692Not Yet Recruiting
Not Applicable
(PREventive Invasive Strategy for Obstructive Coronary Artery Disease With Vulne...CardioVascular Research F...
NCT07570498
Strengthening the Parent-Child Relationship Through Urban NatureThe Chinese University of Hong Kong, ShenzhenCompletedNot Applicable
NCT07570498Completed
Not Applicable
Strengthening the Parent-Child Relationship Through Urban NatureThe Chinese University of...
NCT07570524
Predicting Response to Immunochemotherapy in Early Triple Negative Breast CancerCenter Eugene MarquisNot Yet Recruiting
NCT07570524Not Yet Recruiting
—
Predicting Response to Immunochemotherapy in Early Triple Negative Breast CancerCenter Eugene Marquis
NCT07569432
Investigation of Macrophage Polarization in Peri-implant Health and Peri-implantitisBiruni UniversityNot Yet Recruiting
NCT07569432Not Yet Recruiting
—
Investigation of Macrophage Polarization in Peri-implant Health and Peri-implant...Biruni University
NCT07570667
Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promote Early-stage Disease Detection and Personalized/Precision Care Using Innovative Research PlatformsCenter for Molecular Fingerprinting Research Nonprofit LLCNot Yet Recruiting
NCT07570667Not Yet Recruiting
—
Global Longitudinal Health Monitoring and Blood Sample Collection Study to Promo...Center for Molecular Fing...
NCT07568821
Effectiveness of VR Rehabilitation for People With Asymmetrical Gait PatternsUniversity of RzeszowNot Yet RecruitingNot Applicable
NCT07568821Not Yet Recruiting
Not Applicable
Effectiveness of VR Rehabilitation for People With Asymmetrical Gait PatternsUniversity of Rzeszow
NCT07569081
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With Vacuoles, E1-enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) SyndromeGlaxoSmithKlineNot Yet RecruitingPhase 2
NCT07569081Not Yet Recruiting
Phase 2
A Study Evaluating the Efficacy and Safety of Momelotinib in Participants With V...GlaxoSmithKline
NCT07570589
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evolution of Myasthenia Gravis Symptoms in Real-life in Patients With Anti-AChR and Anti-MUSK Generalised Myasthenia Gravis in Therapy With RYSTIGGO® (Rozanolixizumab)Centre Hospitalier Universitaire de NiceNot Yet Recruiting
NCT07570589Not Yet Recruiting
—
An Observational, Prospective, Multicenter, Open-label Study to Monitor the Evol...Centre Hospitalier Univer...
NCT07570277
Research on the Application of Nursing Intervention Based on ITHBC Theory in Postoperative Self-Management of Patients With Varicose Veins of the Lower ExtremitiesSecond Affiliated Hospital of Nanchang UniversityRecruitingNot Applicable
NCT07570277Recruiting
Not Applicable
Research on the Application of Nursing Intervention Based on ITHBC Theory in Pos...Second Affiliated Hospita...
NCT07569094
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital of Guangzhou Medical UniversityNot Yet Recruiting
NCT07569094Not Yet Recruiting
—
Research Plan for Early Disease Screening Biomarkers in Healthy IndividualsFifth Affiliated Hospital...
NCT07569458
Online Personalized Psychological Intervention for Patients With Heart Disease and Depression or Anxiety (MY-CHOICE)Aalborg University HospitalRecruitingNot Applicable
NCT07569458Recruiting
Not Applicable
Online Personalized Psychological Intervention for Patients With Heart Disease a...Aalborg University Hospit...
NCT07569783
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Nantong UniversityNot Yet RecruitingNot Applicable
NCT07569783Not Yet Recruiting
Not Applicable
tDCS for Reducing the Incidence of OEI After Cesarean SectionAffiliated Hospital of Na...
NCT07570849
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic CholangiocarcinomaShanghai Zhongshan HospitalRecruitingPhase 2
NCT07570849Recruiting
Phase 2
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment f...Shanghai Zhongshan Hospit...
NCT07568769
Exteroceptive Stimulation for Facial Palsy After StrokeUniversity of FaisalabadCompletedNot Applicable
NCT07568769Completed
Not Applicable
Exteroceptive Stimulation for Facial Palsy After StrokeUniversity of Faisalabad
NCT07570810
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DMShanghai Jiao Tong University School of MedicineNot Yet RecruitingNot Applicable
NCT07570810Not Yet Recruiting
Not Applicable
Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD...Shanghai Jiao Tong Univer...
NCT07568587
Myocardial Function Recovery Prediction Post Primary PCI Using the Estimate of Myocardial Salvage in Gated SPECT Early After Acute Myocardial InfarctionFayoum UniversityCompleted
NCT07568587Completed
—
Myocardial Function Recovery Prediction Post Primary PCI Using the Estimate of M...Fayoum University
NCT07571109
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaNovo Nordisk A/SNot Yet RecruitingPhase 3
NCT07571109Not Yet Recruiting
Phase 3
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps...Novo Nordisk A/S
NCT07571343
Fueling Labor: Protein Supplementation for Intrapartum Glucose ControlMedical College of WisconsinNot Yet RecruitingNot Applicable
NCT07571343Not Yet Recruiting
Not Applicable
Fueling Labor: Protein Supplementation for Intrapartum Glucose ControlMedical College of Wiscon...
Result Breakdown
Not yet recruiting12 (60%)
Recruiting4 (20%)
Completed3 (15%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Not Specified8 (40%)
Phase 22 (10%)
Phase 31 (5%)